This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Nordic Congress
Connecting Nordic & Baltic Innovators With Capital
8th–9th October 2024Bella Center, Copenhagen, Denmark

Zaki Salanti
Senior Director, Head of Search & Evaluation at Novo Nordisk A/S


Zaki Salanti is since 2018 Director in Search and Evaluation, Global Business Development at Novo Nordisk. He was previously Director toxicology at Novo Nordisk. Zaki joined Novo Nordisk in 2005.

Zaki has been responsible for the scouting and coordination of evaluation of external innovation in cardiovascular and kidney disease. Besides innovative therapies, the Search and Evaluation team sources and evaluate a broad range of technologies, including new drug delivery systems and protein engineering. Zaki was recently appointed Head of the Search and Evaluation department.

Zaki Salanti's Network

At this event